RVL Pharmaceuticals plc·4

Jan 26, 5:15 PM ET

Schaub James 4

4 · RVL Pharmaceuticals plc · Filed Jan 26, 2023

Insider Transaction Report

Form 4
Period: 2023-01-24
Schaub James
EVP and COO
Transactions
  • Tax Payment

    Ordinary Shares

    2023-01-24$1.26/sh9,608$12,106530,412 total

Documents

1 file
  • 4
    tm234531-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT